
Lisa Henderson discusses how role of social media in post-market adverse event reporting is finally being taken seriously by the FDA.
Lisa Henderson discusses how role of social media in post-market adverse event reporting is finally being taken seriously by the FDA.
20 July, 2015.
July 17, 2015.
A quick countdown of this year's Top 50 movers and shakers.
July 15, 2015.
July 15, 2015.
July 14, 2015.
The European Medicines Agency (EMA) has started a review of human papillomavirus (HPV) vaccines to further clarify aspects of their safety profile.HPVvaccines have been used in around 72 million people worldwide to prevent cervical cancer and other cancers and conditions caused by HPV. Cervical cancer is the fourth most common cause of cancer death in women worldwide.
July 10, 2015.
All indications are that the July 2016 deadline for transition from Europe's eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) to the new Identification of Medicinal Products (IDMP) is not achievable. Sophie Daniels reports.
July 9, 2015.
June 29, 2015.
The Tufts Center for the Study of Drug Development (CSDD) released a new report highlighting innovative approaches across the R&D continuum that pharmaceutical companies are implementing to drive efficiency and lower cost.
June 26, 2015.
June 25, 2015.
June 18, 2015.